FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E
Health System Strengthening

Therapeutics and COVID-19: Living Guideline

02 Dec 2021

The WHO Therapeutics and COVID-19: Living Guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in COVID-19 treatment. This sixth version of the WHO guideline contains nine recommendations, including two new recommendations regarding the use of a combination of neutralizing monoclonal antibodies, casirivimab and imdevimab. No further updates to the previous existing recommendations were made in this latest version. Links to the earlier versions of this guidance are also available on this page. It is a useful document for medical practitioners. Click here to read the guidelines. 

PUBLISHED BY
World Health Organization
YEAR OF PUBLISHING
2021
AUTHORS
World Health Organization

Categories

COVID-19 For implementers
KEY ORGANIZATIONS

FOLLOW US

Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2022 Swasti Health Catalyst